David P. Southwell
Chief Financial Officer, Sunovion Pharmaceuticals Inc.
Companies
- Rocket Pharmaceuticals Inc.Board member Jun 26, 2015 to now1
- PTC TherapeuticsBoard member Jun 19, 2013 to now2
- TScan Therapeutics, Inc.Board member Jul 15, 2021 to Feb 6, 20233
- TScan Therapeutics, Inc.Chief executive officer Jul 15, 2021 to Feb 6, 20233
- Spero Therapeutics, Inc.Board member Feb 6, 2018 to Jun 6, 20184
- Rocket Pharmaceuticals Inc.Chief executive officer Jan 9, 2017 to Jan 24, 20175
- Rocket Pharmaceuticals Inc.President Jan 9, 2017 to Jan 24, 20175
- Rocket Pharmaceuticals Inc.Officer Feb 17, 2015 to Mar 24, 20166
- First Eagle Alternative Capital BDC, Inc.Board member May 17, 2010 to Dec 7, 20107
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
PTC Therapeutics PTCT22,500 shares8$1.4M at $61.38Jan 2, 2026- Rocket Pharmaceuticals Inc. RCKT317,646 shares9$716.3K at $2.25Aug 5, 2026
- TScan Therapeutics, Inc. TCRX171,569 shares10$36.9K at $0.22May 18, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 3, 2026Other 150,000 shares of Rocket Pharmaceuticals Inc.9
- Jun 18, 2026Granted 22,862 shares of Rocket Pharmaceuticals Inc.11
- Jan 2, 2026Granted 4,000 shares of PTC Therapeutics8
- Sep 9, 2025Sold 12,000 shares at $58.34 of PTC Therapeutics12
- Sep 9, 2025Exercised options 12,000 shares at $30.86 of PTC Therapeutics12
- Jun 18, 2025Granted 30,000 shares of Rocket Pharmaceuticals Inc.13
- Jan 3, 2025Granted 4,000 shares of PTC Therapeutics14
- May 8, 2024Gift 1,650 shares of PTC Therapeutics15
- May 2, 2024Gift 59,716 shares of Rocket Pharmaceuticals Inc.16
- May 2, 2024Gift 113,124 shares of Rocket Pharmaceuticals Inc.16
- Apr 15, 2024Sold 10,000 shares at $24.05 of Rocket Pharmaceuticals Inc.17
- Apr 15, 2024Exercised options 29,624 shares at $4.34 of Rocket Pharmaceuticals Inc.17
- Apr 12, 2024Sold 10,284 shares at $25.16 of Rocket Pharmaceuticals Inc.17
- Apr 12, 2024Sold 59,716 shares at $24.22 of Rocket Pharmaceuticals Inc.17
- Apr 12, 2024Exercised options 70,000 shares at $4.34 of Rocket Pharmaceuticals Inc.17
- Feb 15, 2024Granted 4,000 shares of PTC Therapeutics18
- Apr 17, 2023Sold 5,188 shares at $51.43 of PTC Therapeutics19
- Apr 17, 2023Sold 6,241 shares at $50.69 of PTC Therapeutics19
- Apr 17, 2023Exercised options 11,429 shares at $18.01 of PTC Therapeutics19
- Mar 31, 2023Sold 2,571 shares at $50.05 of PTC Therapeutics20
- Mar 31, 2023Exercised options 2,571 shares at $18.01 of PTC Therapeutics20
- Mar 27, 2023Sold 100 shares at $46.03 of PTC Therapeutics21
- Mar 27, 2023Sold 5,301 shares at $45.41 of PTC Therapeutics21
- Mar 27, 2023Sold 4,599 shares at $44.71 of PTC Therapeutics21
- Mar 27, 2023Exercised options 10,000 shares at $27.05 of PTC Therapeutics21
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARPTC Therapeutics, Board member
- 3
- 4
- 5
- 6SEC EDGARRocket Pharmaceuticals Inc., Officer
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jul 6, 2026
- 12SEC EDGARForm 4 filed Sep 11, 2025
- 13SEC EDGARForm 4 filed Jul 18, 2025
- 14SEC EDGARForm 4 filed Jan 7, 2025
- 15SEC EDGARForm 4 filed May 10, 2024
- 16SEC EDGARForm 4 filed May 20, 2024
- 17SEC EDGARForm 4 filed Apr 16, 2024
- 18SEC EDGARForm 4 filed Feb 16, 2024
- 19SEC EDGARForm 4 filed Apr 19, 2023
- 20SEC EDGARForm 4 filed Apr 4, 2023
- 21SEC EDGARForm 4 filed Mar 29, 2023